Exercise intervention lowers aberrant serum WISP-1 levels with insulin resistance in breast cancer survivors: a randomized controlled trial

Insulin resistance is associated with increased risk for and recurrence of breast cancer. Recently, Wnt1-inducible signaling pathway protein-1 (WISP-1) was reported to impair glucose metabolism and insulin sensitivity. In various cancer tissues, Wnt signaling is upregulated and induces further oncog...

Full description

Saved in:
Bibliographic Details
Published inScientific reports Vol. 10; no. 1; p. 10898
Main Authors Chang, Jae Seung, Kim, Tae Ho, Kong, In Deok
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 02.07.2020
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Insulin resistance is associated with increased risk for and recurrence of breast cancer. Recently, Wnt1-inducible signaling pathway protein-1 (WISP-1) was reported to impair glucose metabolism and insulin sensitivity. In various cancer tissues, Wnt signaling is upregulated and induces further oncogenic and metastatic activity. However, the effects of exercise on serum levels of WISP-1 and its upstream β-catenin have not been studied in cancer patients. We investigated the effects of exercise training on Wnt signaling and insulin sensitivity in breast cancer survivors (BCS). This single-center trial randomized 46 BCS into either 12-week exercise or control groups (1:1), and included an additional 12 age-matched healthy women. Kinanthropometric parameters, serum Wnt signaling markers, and gluco-lipid profiles were evaluated before and after the intervention. Serum β-catenin and WISP-1 concentrations were significantly higher in BCS than in healthy subjects. There was a positive correlation between β-catenin and WISP-1 levels. Exercise training in BCS significantly reduced body fat and waist circumference and enhanced aerobic and muscular fitness. Exercise decreased β-catenin and WISP-1 levels and improved gluco-lipid profiles. There was a notable correlation between changes in HOMA-IR indexes and serum WISP-1, but not with β-catenin during the exercise intervention. In conclusion, a 12-week community-based exercise intervention resulted in significant reductions in serum β-catenin and WISP-1 levels, accompanied by favorable improvements in body composition, physical fitness, and biochemical parameters in BCS. We also highlight that this is the first report concerning effects of exercise on circulating β-catenin and WISP-1 levels and correlations between WISP-1 and insulin sensitivity, which could be important for determining prognoses for BCS.
AbstractList Insulin resistance is associated with increased risk for and recurrence of breast cancer. Recently, Wnt1-inducible signaling pathway protein-1 (WISP-1) was reported to impair glucose metabolism and insulin sensitivity. In various cancer tissues, Wnt signaling is upregulated and induces further oncogenic and metastatic activity. However, the effects of exercise on serum levels of WISP-1 and its upstream β-catenin have not been studied in cancer patients. We investigated the effects of exercise training on Wnt signaling and insulin sensitivity in breast cancer survivors (BCS). This single-center trial randomized 46 BCS into either 12-week exercise or control groups (1:1), and included an additional 12 age-matched healthy women. Kinanthropometric parameters, serum Wnt signaling markers, and gluco-lipid profiles were evaluated before and after the intervention. Serum β-catenin and WISP-1 concentrations were significantly higher in BCS than in healthy subjects. There was a positive correlation between β-catenin and WISP-1 levels. Exercise training in BCS significantly reduced body fat and waist circumference and enhanced aerobic and muscular fitness. Exercise decreased β-catenin and WISP-1 levels and improved gluco-lipid profiles. There was a notable correlation between changes in HOMA-IR indexes and serum WISP-1, but not with β-catenin during the exercise intervention. In conclusion, a 12-week community-based exercise intervention resulted in significant reductions in serum β-catenin and WISP-1 levels, accompanied by favorable improvements in body composition, physical fitness, and biochemical parameters in BCS. We also highlight that this is the first report concerning effects of exercise on circulating β-catenin and WISP-1 levels and correlations between WISP-1 and insulin sensitivity, which could be important for determining prognoses for BCS.
Insulin resistance is associated with increased risk for and recurrence of breast cancer. Recently, Wnt1-inducible signaling pathway protein-1 (WISP-1) was reported to impair glucose metabolism and insulin sensitivity. In various cancer tissues, Wnt signaling is upregulated and induces further oncogenic and metastatic activity. However, the effects of exercise on serum levels of WISP-1 and its upstream β-catenin have not been studied in cancer patients. We investigated the effects of exercise training on Wnt signaling and insulin sensitivity in breast cancer survivors (BCS). This single-center trial randomized 46 BCS into either 12-week exercise or control groups (1:1), and included an additional 12 age-matched healthy women. Kinanthropometric parameters, serum Wnt signaling markers, and gluco-lipid profiles were evaluated before and after the intervention. Serum β-catenin and WISP-1 concentrations were significantly higher in BCS than in healthy subjects. There was a positive correlation between β-catenin and WISP-1 levels. Exercise training in BCS significantly reduced body fat and waist circumference and enhanced aerobic and muscular fitness. Exercise decreased β-catenin and WISP-1 levels and improved gluco-lipid profiles. There was a notable correlation between changes in HOMA-IR indexes and serum WISP-1, but not with β-catenin during the exercise intervention. In conclusion, a 12-week community-based exercise intervention resulted in significant reductions in serum β-catenin and WISP-1 levels, accompanied by favorable improvements in body composition, physical fitness, and biochemical parameters in BCS. We also highlight that this is the first report concerning effects of exercise on circulating β-catenin and WISP-1 levels and correlations between WISP-1 and insulin sensitivity, which could be important for determining prognoses for BCS.
Insulin resistance is associated with increased risk for and recurrence of breast cancer. Recently, Wnt1-inducible signaling pathway protein-1 (WISP-1) was reported to impair glucose metabolism and insulin sensitivity. In various cancer tissues, Wnt signaling is upregulated and induces further oncogenic and metastatic activity. However, the effects of exercise on serum levels of WISP-1 and its upstream β-catenin have not been studied in cancer patients. We investigated the effects of exercise training on Wnt signaling and insulin sensitivity in breast cancer survivors (BCS). This single-center trial randomized 46 BCS into either 12-week exercise or control groups (1:1), and included an additional 12 age-matched healthy women. Kinanthropometric parameters, serum Wnt signaling markers, and gluco-lipid profiles were evaluated before and after the intervention. Serum β-catenin and WISP-1 concentrations were significantly higher in BCS than in healthy subjects. There was a positive correlation between β-catenin and WISP-1 levels. Exercise training in BCS significantly reduced body fat and waist circumference and enhanced aerobic and muscular fitness. Exercise decreased β-catenin and WISP-1 levels and improved gluco-lipid profiles. There was a notable correlation between changes in HOMA-IR indexes and serum WISP-1, but not with β-catenin during the exercise intervention. In conclusion, a 12-week community-based exercise intervention resulted in significant reductions in serum β-catenin and WISP-1 levels, accompanied by favorable improvements in body composition, physical fitness, and biochemical parameters in BCS. We also highlight that this is the first report concerning effects of exercise on circulating β-catenin and WISP-1 levels and correlations between WISP-1 and insulin sensitivity, which could be important for determining prognoses for BCS.Insulin resistance is associated with increased risk for and recurrence of breast cancer. Recently, Wnt1-inducible signaling pathway protein-1 (WISP-1) was reported to impair glucose metabolism and insulin sensitivity. In various cancer tissues, Wnt signaling is upregulated and induces further oncogenic and metastatic activity. However, the effects of exercise on serum levels of WISP-1 and its upstream β-catenin have not been studied in cancer patients. We investigated the effects of exercise training on Wnt signaling and insulin sensitivity in breast cancer survivors (BCS). This single-center trial randomized 46 BCS into either 12-week exercise or control groups (1:1), and included an additional 12 age-matched healthy women. Kinanthropometric parameters, serum Wnt signaling markers, and gluco-lipid profiles were evaluated before and after the intervention. Serum β-catenin and WISP-1 concentrations were significantly higher in BCS than in healthy subjects. There was a positive correlation between β-catenin and WISP-1 levels. Exercise training in BCS significantly reduced body fat and waist circumference and enhanced aerobic and muscular fitness. Exercise decreased β-catenin and WISP-1 levels and improved gluco-lipid profiles. There was a notable correlation between changes in HOMA-IR indexes and serum WISP-1, but not with β-catenin during the exercise intervention. In conclusion, a 12-week community-based exercise intervention resulted in significant reductions in serum β-catenin and WISP-1 levels, accompanied by favorable improvements in body composition, physical fitness, and biochemical parameters in BCS. We also highlight that this is the first report concerning effects of exercise on circulating β-catenin and WISP-1 levels and correlations between WISP-1 and insulin sensitivity, which could be important for determining prognoses for BCS.
ArticleNumber 10898
Author Kim, Tae Ho
Kong, In Deok
Chang, Jae Seung
Author_xml – sequence: 1
  givenname: Jae Seung
  orcidid: 0000-0002-4047-1128
  surname: Chang
  fullname: Chang, Jae Seung
  organization: Mitohormesis Research Center, Wonju College of Medicine, Yonsei University, Yonsei Institute of Sports Science and Exercise Medicine
– sequence: 2
  givenname: Tae Ho
  surname: Kim
  fullname: Kim, Tae Ho
  organization: Department of Physiology, Wonju College of Medicine, Yonsei University, Yonsei Institute of Sports Science and Exercise Medicine
– sequence: 3
  givenname: In Deok
  orcidid: 0000-0002-9821-6103
  surname: Kong
  fullname: Kong, In Deok
  email: kong@yonsei.ac.kr
  organization: Department of Physiology, Wonju College of Medicine, Yonsei University, Yonsei Institute of Sports Science and Exercise Medicine
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32616883$$D View this record in MEDLINE/PubMed
BookMark eNp9Ustu1TAQjVARfdAfYIEssWET8CNOHBZIVdVCpUogAWJpOc6kdeVrl7GTC_wCP40vt5TSRb3xWHPO8RzN2a92QgxQVc8YfcWoUK9Tw2Svaspp3XZd39TrR9Uep42sueB85069Wx2mdEXLkbxvWP-k2hW8Za1SYq_6dfId0LoExIUMuEDILgbi4xowETMAogmZJMB5Rb6effpYM-JhAZ_I2uXLwkqzd4EgJJeyCXYjRAYEkzKxmzeSNOPilojpDTGkyI1x5X7CSGwMGaP3pczojH9aPZ6MT3B4cx9UX05PPh-_r88_vDs7PjqvreQ812ICaUcp-DS0g5TKjO2oRjGYzlDJ7GSAKyF7sKAaPrYShm7oqaGmNLqppeKgervVvZ6HFYy2eEbj9TW6lcEfOhqn_-8Ed6kv4qI7IVjb8CLw8kYA47cZUtYrlyx4bwLEOWnecMpkQ1VToC_uQa_ijKHYKyjWS9mplhXU87sT3Y7yd08FwLcAizElhOkWwqje5EFv86BLHvSfPOh1Ial7JOuy2ey3uHL-YarYUlP5J1wA_hv7AdZvnvTO_g
CitedBy_id crossref_primary_10_1177_08445621211062467
crossref_primary_10_1016_j_exger_2021_111435
crossref_primary_10_1186_s12890_024_03048_z
crossref_primary_10_1186_s12967_024_05364_8
crossref_primary_10_3389_fmolb_2022_930361
crossref_primary_10_3390_ijms26051790
crossref_primary_10_1016_j_lfs_2020_118790
crossref_primary_10_3390_medicina57020100
crossref_primary_10_3390_nu13093108
crossref_primary_10_3389_fphys_2022_1033585
crossref_primary_10_59312_ebshealth_1363593
crossref_primary_10_1007_s13304_024_01977_2
crossref_primary_10_1007_s13577_024_01036_3
crossref_primary_10_1097_CAD_0000000000001687
crossref_primary_10_3390_diagnostics13122033
crossref_primary_10_61186_aassjournal_1290
Cites_doi 10.1038/sj.onc.1207892
10.1007/s12282-014-0521-7
10.1002/cncr.27469
10.1016/j.nutres.2012.05.009
10.1111/nyas.14027
10.1002/ijc.26071
10.1007/s11764-017-0657-5
10.1007/s10549-014-3076-6
10.1038/nrd3599
10.1007/s00125-017-4461-6
10.1111/j.1467-789X.2006.00261.x
10.1016/j.biocel.2015.03.007
10.1503/cmaj.051073
10.1016/j.metabol.2014.10.008
10.1038/srep08686
10.1016/j.cell.2017.05.016
10.1200/JCO.2007.15.9822
10.2337/db14-0444
10.1007/BF00280883
10.1016/j.ctrv.2017.11.002
10.2353/ajpath.2010.091125
10.1158/0008-5472.CAN-15-3307
10.2337/dc12-0336
10.1038/sj.onc.1204586
10.1016/j.breast.2017.04.003
10.1136/bmj.e70
10.1007/s11764-019-00747-z
10.1519/JSC.0b013e318245c0c9
10.1016/j.cell.2012.05.012
10.1371/journal.pone.0171771
10.1371/journal.pone.0071709
10.1016/j.devcel.2009.06.016
10.1016/j.biocel.2010.11.013
10.1007/s10549-008-9958-8
10.1249/MSS.0000000000000988
10.1016/j.bbi.2012.05.001
10.1126/science.1094291
10.1007/s00125-018-4636-9
10.1007/s12079-017-0427-1
10.1101/gad.14.5.585
ContentType Journal Article
Copyright The Author(s) 2020
The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2020
– notice: The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88A
88E
88I
8FE
8FH
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M2P
M7P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
Q9U
7X8
5PM
DOI 10.1038/s41598-020-67794-w
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Biological Science Collection
ProQuest Health & Medical Collection
Medical Database
Science Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE
CrossRef


Publicly Available Content Database
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2045-2322
ExternalDocumentID PMC7331642
32616883
10_1038_s41598_020_67794_w
Genre Comparative Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: National Research Foundation of Korea (NRF)
  grantid: NRF-2017R1A5A2015369; NRF-2018R1C1B6005036; NRF-2020R1I1A3070520
– fundername: ;
  grantid: NRF-2017R1A5A2015369; NRF-2018R1C1B6005036; NRF-2020R1I1A3070520
GroupedDBID 0R~
3V.
4.4
53G
5VS
7X7
88A
88E
88I
8FE
8FH
8FI
8FJ
AAFWJ
AAJSJ
AAKDD
ABDBF
ABUWG
ACGFS
ACSMW
ACUHS
ADBBV
ADRAZ
AENEX
AEUYN
AFKRA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
C6C
CCPQU
DIK
DWQXO
EBD
EBLON
EBS
ESX
FYUFA
GNUQQ
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
KQ8
LK8
M0L
M1P
M2P
M48
M7P
M~E
NAO
OK1
PIMPY
PQQKQ
PROAC
PSQYO
RNT
RNTTT
RPM
SNYQT
UKHRP
AASML
AAYXX
AFPKN
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
7XB
8FK
AARCD
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
Q9U
7X8
5PM
ID FETCH-LOGICAL-c522t-3fe5cd532fb6b558ad6d8d3ba7a051cfae28359ece842d65eb7b90a0aae27f603
IEDL.DBID M48
ISSN 2045-2322
IngestDate Thu Aug 21 18:12:16 EDT 2025
Fri Jul 11 05:58:58 EDT 2025
Wed Aug 13 04:34:05 EDT 2025
Thu Jan 02 22:59:18 EST 2025
Tue Jul 01 03:24:35 EDT 2025
Thu Apr 24 23:01:43 EDT 2025
Fri Feb 21 02:38:41 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c522t-3fe5cd532fb6b558ad6d8d3ba7a051cfae28359ece842d65eb7b90a0aae27f603
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Feature-3
ObjectType-Evidence Based Healthcare-1
ObjectType-Feature-1
content type line 23
ObjectType-Undefined-3
ORCID 0000-0002-4047-1128
0000-0002-9821-6103
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1038/s41598-020-67794-w
PMID 32616883
PQID 2419557861
PQPubID 2041939
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_7331642
proquest_miscellaneous_2420154084
proquest_journals_2419557861
pubmed_primary_32616883
crossref_primary_10_1038_s41598_020_67794_w
crossref_citationtrail_10_1038_s41598_020_67794_w
springer_journals_10_1038_s41598_020_67794_w
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2020-07-02
PublicationDateYYYYMMDD 2020-07-02
PublicationDate_xml – month: 07
  year: 2020
  text: 2020-07-02
  day: 02
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Scientific reports
PublicationTitleAbbrev Sci Rep
PublicationTitleAlternate Sci Rep
PublicationYear 2020
Publisher Nature Publishing Group UK
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
References Murahovschi (CR18) 2015; 64
Brown (CR28) 2018; 12
Buchan, Janda, Box, Schmitz, Hayes (CR29) 2016; 48
MacDonald, Tamai, He (CR12) 2009; 17
Niida (CR30) 2004; 23
Betof, Dewhirst, Jones (CR43) 2013; 30
Chiang (CR15) 2015; 5
Mendonca (CR20) 2015; 64
Esposito, Chiodini, Colao, Lenzi, Giugliano (CR38) 2012; 35
Michaelson, Leder (CR32) 2001; 20
Fong (CR2) 2012; 344
Jun, Lau (CR35) 2011; 10
Ono (CR36) 2013; 8
CR17
Colado (CR25) 2012; 26
CR16
Ghosh, Hossain, Mandal, Sil (CR8) 2019; 1443
Jones (CR42) 2016; 76
Sieri (CR37) 2012; 130
Berschneider, Konigshoff (CR13) 2011; 43
Krishnamurthy, Kurzrock (CR9) 2018; 62
Carmichael (CR21) 2006; 7
Zeng, Huang, Cheng, Zhou, So (CR4) 2014; 21
Gurbuz, Chiquet-Ehrismann (CR14) 2015; 62
Cust (CR19) 2009; 113
Anderson, Erceg, Schroeder (CR26) 2012; 32
Nelson, Nusse (CR11) 2004; 303
Nusse, Clevers (CR7) 2017; 169
McNeely (CR6) 2006; 175
Clevers, Nusse (CR10) 2012; 149
Xu, Corcoran, Welsh, Pennica, Levine (CR31) 2000; 14
Binkley (CR3) 2012; 118
Irwin (CR41) 2008; 26
Juvet (CR1) 2017; 33
Xie, Nakachi, Wang, Elashoff, Koeffler (CR34) 2001; 61
Mijwel (CR5) 2019; 13
CR24
CR23
Matthews (CR27) 1985; 28
Berrino (CR39) 2014; 147
Sparks (CR40) 2017; 60
Kim (CR22) 2017; 12
Khramtsov (CR33) 2010; 176
B Berschneider (67794_CR13) 2011; 43
K Esposito (67794_CR38) 2012; 35
LM Sparks (67794_CR40) 2017; 60
JM Binkley (67794_CR3) 2012; 118
R Nusse (67794_CR7) 2017; 169
LK Juvet (67794_CR1) 2017; 33
H Clevers (67794_CR10) 2012; 149
67794_CR17
TH Kim (67794_CR22) 2017; 12
67794_CR16
Y Zeng (67794_CR4) 2014; 21
D Xie (67794_CR34) 2001; 61
M Ono (67794_CR36) 2013; 8
AI Khramtsov (67794_CR33) 2010; 176
ML Irwin (67794_CR41) 2008; 26
F Berrino (67794_CR39) 2014; 147
FM Mendonca (67794_CR20) 2015; 64
67794_CR24
67794_CR23
AR Carmichael (67794_CR21) 2006; 7
JS Michaelson (67794_CR32) 2001; 20
DY Fong (67794_CR2) 2012; 344
S Mijwel (67794_CR5) 2019; 13
N Ghosh (67794_CR8) 2019; 1443
LJ Anderson (67794_CR26) 2012; 32
V Murahovschi (67794_CR18) 2015; 64
JC Colado (67794_CR25) 2012; 26
JI Jun (67794_CR35) 2011; 10
AS Betof (67794_CR43) 2013; 30
N Krishnamurthy (67794_CR9) 2018; 62
A Niida (67794_CR30) 2004; 23
WJ Nelson (67794_CR11) 2004; 303
JC Brown (67794_CR28) 2018; 12
J Buchan (67794_CR29) 2016; 48
KC Chiang (67794_CR15) 2015; 5
L Xu (67794_CR31) 2000; 14
LW Jones (67794_CR42) 2016; 76
BT MacDonald (67794_CR12) 2009; 17
DR Matthews (67794_CR27) 1985; 28
ML McNeely (67794_CR6) 2006; 175
AE Cust (67794_CR19) 2009; 113
I Gurbuz (67794_CR14) 2015; 62
S Sieri (67794_CR37) 2012; 130
References_xml – volume: 23
  start-page: 8520
  year: 2004
  end-page: 8526
  ident: CR30
  article-title: DKK1, a negative regulator of Wnt signaling, is a target of the beta-catenin/TCF pathway
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1207892
– volume: 14
  start-page: 585
  year: 2000
  end-page: 595
  ident: CR31
  article-title: WISP-1 is a Wnt-1- and beta-catenin-responsive oncogene
  publication-title: Genes Dev
– volume: 21
  start-page: 262
  year: 2014
  end-page: 274
  ident: CR4
  article-title: Meta-analysis of the effects of exercise intervention on quality of life in breast cancer survivors
  publication-title: Breast Cancer
  doi: 10.1007/s12282-014-0521-7
– volume: 118
  start-page: 2207
  year: 2012
  end-page: 2216
  ident: CR3
  article-title: Patient perspectives on breast cancer treatment side effects and the prospective surveillance model for physical rehabilitation for women with breast cancer
  publication-title: Cancer
  doi: 10.1002/cncr.27469
– volume: 32
  start-page: 479
  year: 2012
  end-page: 485
  ident: CR26
  article-title: Utility of multifrequency bioelectrical impedance compared with dual-energy x-ray absorptiometry for assessment of total and regional body composition varies between men and women
  publication-title: Nutr. Res.
  doi: 10.1016/j.nutres.2012.05.009
– volume: 1443
  start-page: 54
  year: 2019
  end-page: 74
  ident: CR8
  article-title: The Wnt signaling pathway: a potential therapeutic target against cancer
  publication-title: Ann. N. Y. Acad. Sci.
  doi: 10.1111/nyas.14027
– volume: 130
  start-page: 921
  year: 2012
  end-page: 929
  ident: CR37
  article-title: Prospective study on the role of glucose metabolism in breast cancer occurrence
  publication-title: Int J Cancer
  doi: 10.1002/ijc.26071
– volume: 12
  start-page: 186
  year: 2018
  end-page: 195
  ident: CR28
  article-title: Randomized trial of a clinic-based weight loss intervention in cancer survivors
  publication-title: J Cancer Surviv.
  doi: 10.1007/s11764-017-0657-5
– ident: CR16
– volume: 147
  start-page: 159
  year: 2014
  end-page: 165
  ident: CR39
  article-title: Metabolic syndrome and breast cancer prognosis
  publication-title: Breast Cancer Res. Treat.
  doi: 10.1007/s10549-014-3076-6
– volume: 10
  start-page: 945
  year: 2011
  end-page: 963
  ident: CR35
  article-title: Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets
  publication-title: Nat Rev Drug Discov
  doi: 10.1038/nrd3599
– volume: 60
  start-page: 2329
  year: 2017
  end-page: 2336
  ident: CR40
  article-title: Exercise training response heterogeneity: physiological and molecular insights
  publication-title: Diabetologia
  doi: 10.1007/s00125-017-4461-6
– volume: 7
  start-page: 333
  year: 2006
  end-page: 340
  ident: CR21
  article-title: Obesity and prognosis of breast cancer
  publication-title: Obes Rev
  doi: 10.1111/j.1467-789X.2006.00261.x
– volume: 62
  start-page: 142
  year: 2015
  end-page: 146
  ident: CR14
  article-title: CCN4/WISP1 (WNT1 inducible signaling pathway protein 1): a focus on its role in cancer
  publication-title: Int J Biochem Cell Biol
  doi: 10.1016/j.biocel.2015.03.007
– volume: 175
  start-page: 34
  year: 2006
  end-page: 41
  ident: CR6
  article-title: Effects of exercise on breast cancer patients and survivors: a systematic review and meta-analysis
  publication-title: CMAJ
  doi: 10.1503/cmaj.051073
– volume: 64
  start-page: 182
  year: 2015
  end-page: 189
  ident: CR20
  article-title: Metabolic syndrome and risk of cancer: which link?
  publication-title: Metabolism
  doi: 10.1016/j.metabol.2014.10.008
– volume: 5
  start-page: 8686
  year: 2015
  ident: CR15
  article-title: WNT-1 inducible signaling pathway protein-1 enhances growth and tumorigenesis in human breast cancer
  publication-title: Sci. Rep.
  doi: 10.1038/srep08686
– volume: 169
  start-page: 985
  year: 2017
  end-page: 999
  ident: CR7
  article-title: Wnt/beta-catenin signaling, disease, and emerging therapeutic modalities
  publication-title: Cell
  doi: 10.1016/j.cell.2017.05.016
– volume: 61
  start-page: 8917
  year: 2001
  end-page: 8923
  ident: CR34
  article-title: Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features
  publication-title: Cancer Res
– volume: 26
  start-page: 3958
  year: 2008
  end-page: 3964
  ident: CR41
  article-title: Influence of pre- and postdiagnosis physical activity on mortality in breast cancer survivors: the health, eating, activity, and lifestyle study
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2007.15.9822
– volume: 64
  start-page: 856
  year: 2015
  end-page: 866
  ident: CR18
  article-title: WISP1 is a novel adipokine linked to inflammation in obesity
  publication-title: Diabetes
  doi: 10.2337/db14-0444
– volume: 28
  start-page: 412
  year: 1985
  end-page: 419
  ident: CR27
  article-title: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
  publication-title: Diabetologia
  doi: 10.1007/BF00280883
– volume: 62
  start-page: 50
  year: 2018
  end-page: 60
  ident: CR9
  article-title: Targeting the Wnt/beta-catenin pathway in cancer: update on effectors and inhibitors
  publication-title: Cancer Treat. Rev.
  doi: 10.1016/j.ctrv.2017.11.002
– volume: 176
  start-page: 2911
  year: 2010
  end-page: 2920
  ident: CR33
  article-title: Wnt/beta-catenin pathway activation is enriched in basal-like breast cancers and predicts poor outcome
  publication-title: Am J Pathol
  doi: 10.2353/ajpath.2010.091125
– volume: 76
  start-page: 5415
  year: 2016
  end-page: 5422
  ident: CR42
  article-title: Exercise and prognosis on the basis of clinicopathologic and molecular features in early-stage breast cancer: the LACE and pathways studies
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-15-3307
– volume: 35
  start-page: 2402
  year: 2012
  end-page: 2411
  ident: CR38
  article-title: Metabolic syndrome and risk of cancer: a systematic review and meta-analysis
  publication-title: Diabetes Care
  doi: 10.2337/dc12-0336
– ident: CR23
– volume: 20
  start-page: 5093
  year: 2001
  end-page: 5099
  ident: CR32
  article-title: beta-catenin is a downstream effector of Wnt-mediated tumorigenesis in the mammary gland
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1204586
– volume: 33
  start-page: 166
  year: 2017
  end-page: 177
  ident: CR1
  article-title: The effect of exercise on fatigue and physical functioning in breast cancer patients during and after treatment and at 6 months follow-up: a meta-analysis
  publication-title: Breast
  doi: 10.1016/j.breast.2017.04.003
– volume: 344
  start-page: e70
  year: 2012
  ident: CR2
  article-title: Physical activity for cancer survivors: meta-analysis of randomised controlled trials
  publication-title: BMJ
  doi: 10.1136/bmj.e70
– volume: 13
  start-page: 244
  year: 2019
  end-page: 256
  ident: CR5
  article-title: High-intensity exercise during chemotherapy induces beneficial effects 12 months into breast cancer survivorship
  publication-title: J. Cancer Surviv.
  doi: 10.1007/s11764-019-00747-z
– volume: 26
  start-page: 3018
  year: 2012
  end-page: 3024
  ident: CR25
  article-title: Concurrent validation of the OMNI-resistance exercise scale of perceived exertion with Thera-band resistance bands
  publication-title: J. Strength Cond. Res.
  doi: 10.1519/JSC.0b013e318245c0c9
– volume: 149
  start-page: 1192
  year: 2012
  end-page: 1205
  ident: CR10
  article-title: Wnt/beta-catenin signaling and disease
  publication-title: Cell
  doi: 10.1016/j.cell.2012.05.012
– volume: 12
  start-page: e0171771
  year: 2017
  ident: CR22
  article-title: Effects of exercise training on circulating levels of Dickkpof-1 and secreted frizzled-related protein-1 in breast cancer survivors: A pilot single-blind randomized controlled trial
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0171771
– ident: CR17
– volume: 8
  start-page: e71709
  year: 2013
  ident: CR36
  article-title: WISP1/CCN4: a potential target for inhibiting prostate cancer growth and spread to bone
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0071709
– volume: 17
  start-page: 9
  year: 2009
  end-page: 26
  ident: CR12
  article-title: Wnt/beta-catenin signaling: components, mechanisms, and diseases
  publication-title: Dev. Cell
  doi: 10.1016/j.devcel.2009.06.016
– volume: 43
  start-page: 306
  year: 2011
  end-page: 309
  ident: CR13
  article-title: WNT1 inducible signaling pathway protein 1 (WISP1): a novel mediator linking development and disease
  publication-title: Int. J. Biochem. Cell Biol.
  doi: 10.1016/j.biocel.2010.11.013
– volume: 113
  start-page: 567
  year: 2009
  end-page: 576
  ident: CR19
  article-title: The influence of overweight and insulin resistance on breast cancer risk and tumour stage at diagnosis: a prospective study
  publication-title: Breast Cancer Res. Treat.
  doi: 10.1007/s10549-008-9958-8
– volume: 48
  start-page: 1866
  year: 2016
  end-page: 1874
  ident: CR29
  article-title: A randomized trial on the effect of exercise mode on breast cancer-related lymphedema
  publication-title: Med. Sci. Sports Exerc.
  doi: 10.1249/MSS.0000000000000988
– volume: 30
  start-page: S75
  issue: Suppl
  year: 2013
  end-page: 87
  ident: CR43
  article-title: Effects and potential mechanisms of exercise training on cancer progression: a translational perspective
  publication-title: Brain Behav. Immun.
  doi: 10.1016/j.bbi.2012.05.001
– volume: 303
  start-page: 1483
  year: 2004
  end-page: 1487
  ident: CR11
  article-title: Convergence of Wnt, beta-catenin, and cadherin pathways
  publication-title: Science
  doi: 10.1126/science.1094291
– ident: CR24
– volume: 20
  start-page: 5093
  year: 2001
  ident: 67794_CR32
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1204586
– volume: 64
  start-page: 856
  year: 2015
  ident: 67794_CR18
  publication-title: Diabetes
  doi: 10.2337/db14-0444
– volume: 30
  start-page: S75
  issue: Suppl
  year: 2013
  ident: 67794_CR43
  publication-title: Brain Behav. Immun.
  doi: 10.1016/j.bbi.2012.05.001
– volume: 62
  start-page: 142
  year: 2015
  ident: 67794_CR14
  publication-title: Int J Biochem Cell Biol
  doi: 10.1016/j.biocel.2015.03.007
– volume: 147
  start-page: 159
  year: 2014
  ident: 67794_CR39
  publication-title: Breast Cancer Res. Treat.
  doi: 10.1007/s10549-014-3076-6
– volume: 12
  start-page: e0171771
  year: 2017
  ident: 67794_CR22
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0171771
– volume: 26
  start-page: 3958
  year: 2008
  ident: 67794_CR41
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2007.15.9822
– ident: 67794_CR23
– ident: 67794_CR17
  doi: 10.1007/s00125-018-4636-9
– volume: 303
  start-page: 1483
  year: 2004
  ident: 67794_CR11
  publication-title: Science
  doi: 10.1126/science.1094291
– volume: 7
  start-page: 333
  year: 2006
  ident: 67794_CR21
  publication-title: Obes Rev
  doi: 10.1111/j.1467-789X.2006.00261.x
– volume: 130
  start-page: 921
  year: 2012
  ident: 67794_CR37
  publication-title: Int J Cancer
  doi: 10.1002/ijc.26071
– volume: 118
  start-page: 2207
  year: 2012
  ident: 67794_CR3
  publication-title: Cancer
  doi: 10.1002/cncr.27469
– volume: 32
  start-page: 479
  year: 2012
  ident: 67794_CR26
  publication-title: Nutr. Res.
  doi: 10.1016/j.nutres.2012.05.009
– volume: 23
  start-page: 8520
  year: 2004
  ident: 67794_CR30
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1207892
– volume: 76
  start-page: 5415
  year: 2016
  ident: 67794_CR42
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-15-3307
– volume: 12
  start-page: 186
  year: 2018
  ident: 67794_CR28
  publication-title: J Cancer Surviv.
  doi: 10.1007/s11764-017-0657-5
– volume: 175
  start-page: 34
  year: 2006
  ident: 67794_CR6
  publication-title: CMAJ
  doi: 10.1503/cmaj.051073
– volume: 5
  start-page: 8686
  year: 2015
  ident: 67794_CR15
  publication-title: Sci. Rep.
  doi: 10.1038/srep08686
– volume: 26
  start-page: 3018
  year: 2012
  ident: 67794_CR25
  publication-title: J. Strength Cond. Res.
  doi: 10.1519/JSC.0b013e318245c0c9
– volume: 176
  start-page: 2911
  year: 2010
  ident: 67794_CR33
  publication-title: Am J Pathol
  doi: 10.2353/ajpath.2010.091125
– volume: 8
  start-page: e71709
  year: 2013
  ident: 67794_CR36
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0071709
– ident: 67794_CR24
– volume: 10
  start-page: 945
  year: 2011
  ident: 67794_CR35
  publication-title: Nat Rev Drug Discov
  doi: 10.1038/nrd3599
– volume: 344
  start-page: e70
  year: 2012
  ident: 67794_CR2
  publication-title: BMJ
  doi: 10.1136/bmj.e70
– volume: 13
  start-page: 244
  year: 2019
  ident: 67794_CR5
  publication-title: J. Cancer Surviv.
  doi: 10.1007/s11764-019-00747-z
– volume: 17
  start-page: 9
  year: 2009
  ident: 67794_CR12
  publication-title: Dev. Cell
  doi: 10.1016/j.devcel.2009.06.016
– ident: 67794_CR16
  doi: 10.1007/s12079-017-0427-1
– volume: 149
  start-page: 1192
  year: 2012
  ident: 67794_CR10
  publication-title: Cell
  doi: 10.1016/j.cell.2012.05.012
– volume: 28
  start-page: 412
  year: 1985
  ident: 67794_CR27
  publication-title: Diabetologia
  doi: 10.1007/BF00280883
– volume: 21
  start-page: 262
  year: 2014
  ident: 67794_CR4
  publication-title: Breast Cancer
  doi: 10.1007/s12282-014-0521-7
– volume: 14
  start-page: 585
  year: 2000
  ident: 67794_CR31
  publication-title: Genes Dev
  doi: 10.1101/gad.14.5.585
– volume: 113
  start-page: 567
  year: 2009
  ident: 67794_CR19
  publication-title: Breast Cancer Res. Treat.
  doi: 10.1007/s10549-008-9958-8
– volume: 61
  start-page: 8917
  year: 2001
  ident: 67794_CR34
  publication-title: Cancer Res
– volume: 33
  start-page: 166
  year: 2017
  ident: 67794_CR1
  publication-title: Breast
  doi: 10.1016/j.breast.2017.04.003
– volume: 64
  start-page: 182
  year: 2015
  ident: 67794_CR20
  publication-title: Metabolism
  doi: 10.1016/j.metabol.2014.10.008
– volume: 60
  start-page: 2329
  year: 2017
  ident: 67794_CR40
  publication-title: Diabetologia
  doi: 10.1007/s00125-017-4461-6
– volume: 43
  start-page: 306
  year: 2011
  ident: 67794_CR13
  publication-title: Int. J. Biochem. Cell Biol.
  doi: 10.1016/j.biocel.2010.11.013
– volume: 1443
  start-page: 54
  year: 2019
  ident: 67794_CR8
  publication-title: Ann. N. Y. Acad. Sci.
  doi: 10.1111/nyas.14027
– volume: 169
  start-page: 985
  year: 2017
  ident: 67794_CR7
  publication-title: Cell
  doi: 10.1016/j.cell.2017.05.016
– volume: 62
  start-page: 50
  year: 2018
  ident: 67794_CR9
  publication-title: Cancer Treat. Rev.
  doi: 10.1016/j.ctrv.2017.11.002
– volume: 48
  start-page: 1866
  year: 2016
  ident: 67794_CR29
  publication-title: Med. Sci. Sports Exerc.
  doi: 10.1249/MSS.0000000000000988
– volume: 35
  start-page: 2402
  year: 2012
  ident: 67794_CR38
  publication-title: Diabetes Care
  doi: 10.2337/dc12-0336
SSID ssj0000529419
Score 2.4020495
Snippet Insulin resistance is associated with increased risk for and recurrence of breast cancer. Recently, Wnt1-inducible signaling pathway protein-1 (WISP-1) was...
SourceID pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 10898
SubjectTerms 692/308/2779/777
692/699/67/1347
692/700/459/284
beta Catenin - blood
Biomarkers
Blood Glucose - analysis
Body Composition
Body fat
Breast cancer
Breast Neoplasms - blood
Breast Neoplasms - rehabilitation
Cancer Survivors
CCN Intercellular Signaling Proteins - blood
Exercise
Exercise Therapy
Fitness training programs
Glucose metabolism
Humanities and Social Sciences
Humans
Insulin
Insulin Resistance
Lipids - blood
Metastases
Middle Aged
multidisciplinary
Physical Fitness
Physical training
Prognosis
Proto-Oncogene Proteins - blood
Resistance Training
Science
Science (multidisciplinary)
Serum levels
Signal transduction
Wnt protein
Wnt Signaling Pathway
β-Catenin
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fb9MwED7BEBIvE7_JGOiQeINoSZzYCS8IoU0DCYQEE32LbMcRlbpka9JN8C_sn95d4maUib21tdM0vTvf-e7zfQCvCyuLuCb7lolJQ_K3ItQMphKZK4QUykYpnx3-8lUeHqWfZ9nMJ9w6D6tcr4nDQl21lnPke-RpiozUS8bvT05DZo3i6qqn0LgNd7h1GWu1mqkpx8JVLLrMn5WJRL7Xkb_iM2W8Z1KkiuH5pj-6FmRex0r-UzAd_NDBfdj2ASR-GCX-AG655iHcHSklfz-Ci33PoYTzv9CMuBjI0FAbtyTn1CMp3uoYf376_i2MccHAoQ45JYsem460C-fIklSCPkLD0PUeLb9fYrei9eWsXXbvUCN9XdUez_-4Cj3sfUEvBzKQx3B0sP_j42HoCRdCS2FYH4raZbbKRFIbabIs15Ws8koYrTTZrq214-5shbMuT5NKZs4oU0Q60jSgahmJJ7DVtI17BpjQvlvXzqmCe6BpWygrY1m7lAGgFFYGEK__9tL6buRMirEoh6q4yMtRVCWJqhxEVZ4H8Ga65mTsxXHj7N21NEtvl115pUUBvJqGyaK4TKIb1654TsKBZZSnATwdhT_djoLdWOa5CEBtqMU0gbt1b440819D124mx6TNXgBv1wp09bP-_xQ7Nz_Fc7iXsDJzvjnZha1-uXIvKErqzcvBFC4BvgoS8w
  priority: 102
  providerName: ProQuest
– databaseName: Springer Nature HAS Fully OA
  dbid: AAJSJ
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Nb9QwEB2VVkhcKigfTSnISNwgIokTJ-a2Qq3alYqQSkVvke04YqVtttpkW8Ff4E8z4ziBpbRSb0nsJE5mxvNsP88AvJVGyLhG-xaJTkP0tzxURKbimZVc8NxEKe0dPvksjs7S6Xl2vgHJsBfGkfZdSEvXTQ_ssA8tOhraDEaDnRx1KLx-AFsUqh11e2symZ5Ox5kVWrtKY-l3yES8-M_N617oBrS8yZD8Z5nUeZ_Dx7DtYSOb9A19Ahu22YGHfSLJH0_h14HPnMRmf3EY2dylQGNK2yW6pI6huq0u2Lfj0y9hzOZEF2oZTcQyz0hnOPYmPImKgJeYJsJ6xwydL1m7wl7larFsPzLF8HHV4mL201bMk93neOhSgDyDs8ODr5-OQp9mITQIvrqQ1zYzVcaTWgudZYWqRFVUXKtcocWaWlmKySatsUWaVCKzOtcyUpHCgrwWEX8Om82isbvAEhxtq9raXFLkM2VkbkQsapsS7RPBZADx8NtL42OQUyqMeenWwnlR9qIqUVSlE1V5HcC78Z7LPgLHnbX3B2mW3hrbElGKzLBrEnEAb8ZitCNaHFGNXayoTkJwMirSAF70wh9fhxA3FkXBA8jX1GKsQDG610ua2XcXq5tSYuIQL4D3gwL9adbtX7F3v-ov4VFCyk2zzsk-bHbLlX2FWKnTr71x_AbaFxKs
  priority: 102
  providerName: Springer Nature
Title Exercise intervention lowers aberrant serum WISP-1 levels with insulin resistance in breast cancer survivors: a randomized controlled trial
URI https://link.springer.com/article/10.1038/s41598-020-67794-w
https://www.ncbi.nlm.nih.gov/pubmed/32616883
https://www.proquest.com/docview/2419557861
https://www.proquest.com/docview/2420154084
https://pubmed.ncbi.nlm.nih.gov/PMC7331642
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1tb9MwED7tRUh8QbyTMSoj8Q0CTZzYMRJCpeo0Km2aGBX9FjmOIyplKUtSxvgL_Gnu8lIoG0h8ShM7aZu78z1nn-8BeKaMUF6G9i38JHDR33JXUzIVD63igkszDGjv8NGxOJwF03k434Ke7qh7gdW1oR3xSc3K_OW388u3aPBv2i3j0asKnRBtFKNASKJ-uRfbsIueSRKjwVEH99ta374KPNXtnbn-1k3_dAV0Xs2d_GMBtfFLB7fhVgco2ajVgDuwZYu7cKOlmLy8Bz8mHacSW_yW3cjyhhyN6cSW6Kxqhoq4OmOf3p-euB7LKZGoYjRFy7pcdYZROSFNVBG8xBJKZa-ZofOSVSscb74uy-o10wwfly7PFt9tyro0-Bw_NuQg92F2MPk4PnQ7AgbXICyrXZ7Z0KQh97NEJGEY6VSkUcoTLTXassm0pWptyhobBX4qQpvIRA31UGODzMSQP4CdYlnYR8B8jMN1Zq1UVBNNGyWN8ERmA0oIRZjpgNe_9th01cmJJCOPm1VyHsWtqGIUVdyIKr5w4Pn6ni9tbY5_9t7vpRn3ahajlqgQBy3hOfB03YwWRssmurDLFfXxCWgOo8CBh63w11-H4NcTUcQdkBtqse5A1bs3W4rF56aKN5FlYvDnwItegX79rL__i73_6_4Ybvqk3DQf7e_DTl2u7BNEUXUygG05lwPYHY2mp1M8vpscn3zAq2MxHjQzE4PGeH4Cwdkgzg
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3bbtQwEB2VIgQviDuBAkaCJ4iaxImdICGEoNUuvQiJVuyb6ziOWGmblE2WVfkF_oVvZCa3slT0rW9J7GSTnWPPjOd4BuBFYkTi5zi-RZCGLupb7moiU_HIJlxwabyQ9g7v7YvRYfhpEk3W4He_F4Zolf2c2EzUWWlojXwTNU0SIbyE_-7ku0tVoyi62pfQaGGxY0-X6LJVb8cfUb4vg2B76-DDyO2qCrgGbY3a5bmNTBbxIE9FGkWxzkQWZzzVUiNATa4tpSBLrLFxGGQisqlME097GhtkLjyOz70CV1HxeuTsyYkc1nQoaoav2e3N8Xi8WaF-pD1s5KNJhL67XNV_54za89zMfwK0jd7bvgU3O4OVvW8RdhvWbHEHrrUlLE_vwq-trmYTm_7FnmSzpvga06mdozKsGQJ9ccy-jr98dn02I6JSxWgJmHVceIZeP1myCEG8xFKiytfM0PmcVQucz36U8-oN0wwfl5XH0582Yx3NfoaHTfGRe3B4KaK4D-tFWdiHwAL083VurUwo55o2iTTCF7kNiXCKZqwDfv-3K9NlP6ciHDPVROF5rFpRKRSVakSllg68Gu45aXN_XNh7o5em6uaBSp2h1oHnQzOOYArL6MKWC-oTkCHrxaEDD1rhDz-HxrUv4pg7IFdgMXSg7OCrLcX0W5MlnIpxonPpwOseQGev9f-veHTxVzyD66ODvV21O97feQw3AgI2rXUHG7Bezxf2CVpodfq0GRYMji57HP4BhFVRwA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtNAEB6VVCAuiH9cCiwSnMCK7bXXNhJCQBM1FKIIqNqbWa_XaqTULrZDVF6BN-LpmPFfCRW99ZZkN46d-WZnZufbGYBnoRKhnaJ-Cyd2TbS33JREpuKeDrngvrJcOjv8aSp2990Ph97hBvzuzsIQrbJbE-uFOskV7ZEP0dKEHsJL2MO0pUXMdsZvTr6b1EGKMq1dO40GInv6dIXhW_l6soOyfu4449HX97tm22HAVOh3VCZPtacSjztpLGLPC2QikiDhsfQlglWlUlM5slArHbhOIjwd-3FoSUvigJ8Ki-N1r8CmT1HRADbfjaazz_0OD-XQ8KbbkzoWD4YlWks60UYRm4-KYK7WreE5F_c8U_OfdG1tBcc34UbrvrK3Dd5uwYbObsPVpqHl6R34NWo7OLH5X1xKtqhbsTEZ6wJNY8UQ9stjdjD5MjNttiDaUsloQ5i1zHhW6JL8WgQkfsRiIs5XTNH7gpVLXN1-5EX5ikmGl0vy4_lPnbCWdL_Al3UrkruwfynCuAeDLM_0A2AORv0y1doPqQKbVKGvhC1S7RL9FJ1aA-zub49UWwudWnIsojonz4OoEVWEoopqUUUrA1703zlpKoFcOHu7k2bUrgpldIZhA572w6jPlKSRmc6XNMcht9YKXAPuN8Lvfw5dbVsEATfAX4NFP4Fqha-PZPOjumY4tebEUNOAlx2Azm7r_0-xdfFTPIFrqIPRx8l07yFcdwjXtPHtbMOgKpb6EbprVfy41QsG3y5bFf8At6JXWw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Exercise+intervention+lowers+aberrant+serum+WISP-1+levels+with+insulin+resistance+in+breast+cancer+survivors%3A+a+randomized+controlled+trial&rft.jtitle=Scientific+reports&rft.au=Chang%2C+Jae+Seung&rft.au=Kim%2C+Tae+Ho&rft.au=Kong%2C+In+Deok&rft.date=2020-07-02&rft.pub=Nature+Publishing+Group+UK&rft.eissn=2045-2322&rft.volume=10&rft.issue=1&rft_id=info:doi/10.1038%2Fs41598-020-67794-w&rft.externalDocID=10_1038_s41598_020_67794_w
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon